{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "417ddabb-56b5-44bf-9123-61c1d7329277",
   "metadata": {},
   "source": [
    "# Fix the Model ID Formatting in the Models Sheet\n",
    "## Date: 2022-02-18\n",
    "## Author: Jeffrey Grover\n",
    "**Purpose:** Fix the model ID for BCM and HCI to match the correct formatting."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "440996cf-63ce-4fdb-a5de-728be8eed62f",
   "metadata": {},
   "source": [
    "### Load libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "82e35325-cfb3-431d-8269-b77180979be3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "── \u001b[1mAttaching packages\u001b[22m ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── tidyverse 1.3.1 ──\n",
      "\n",
      "\u001b[32m✔\u001b[39m \u001b[34mggplot2\u001b[39m 3.3.5     \u001b[32m✔\u001b[39m \u001b[34mpurrr  \u001b[39m 0.3.4\n",
      "\u001b[32m✔\u001b[39m \u001b[34mtibble \u001b[39m 3.1.6     \u001b[32m✔\u001b[39m \u001b[34mdplyr  \u001b[39m 1.0.7\n",
      "\u001b[32m✔\u001b[39m \u001b[34mtidyr  \u001b[39m 1.1.4     \u001b[32m✔\u001b[39m \u001b[34mstringr\u001b[39m 1.4.0\n",
      "\u001b[32m✔\u001b[39m \u001b[34mreadr  \u001b[39m 2.1.1     \u001b[32m✔\u001b[39m \u001b[34mforcats\u001b[39m 0.5.1\n",
      "\n",
      "── \u001b[1mConflicts\u001b[22m ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── tidyverse_conflicts() ──\n",
      "\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mfilter()\u001b[39m masks \u001b[34mstats\u001b[39m::filter()\n",
      "\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mlag()\u001b[39m    masks \u001b[34mstats\u001b[39m::lag()\n",
      "\n"
     ]
    }
   ],
   "source": [
    "library(tidyverse)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a765b25-933d-4985-bc7b-7aeff1169d0d",
   "metadata": {},
   "source": [
    "### Load the metadata"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d410f007-3940-48ed-a0da-fe362fb8362c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "New names:\n",
      "* `` -> ...1\n",
      "\n",
      "\u001b[1mRows: \u001b[22m\u001b[34m334\u001b[39m \u001b[1mColumns: \u001b[22m\u001b[34m21\u001b[39m\n",
      "\n",
      "\u001b[36m──\u001b[39m \u001b[1mColumn specification\u001b[22m \u001b[36m──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────\u001b[39m\n",
      "\u001b[1mDelimiter:\u001b[22m \",\"\n",
      "\u001b[31mchr\u001b[39m  (18): PDXSource, Contributor, ContributorPDX.ID, PDMR.Patient.ID, Gende...\n",
      "\u001b[32mdbl\u001b[39m   (2): ...1, CTEP.SDCCode\n",
      "\u001b[34mdttm\u001b[39m  (1): Submission\n",
      "\n",
      "\n",
      "\u001b[36mℹ\u001b[39m Use \u001b[30m\u001b[47m\u001b[30m\u001b[47m`spec()`\u001b[47m\u001b[30m\u001b[49m\u001b[39m to retrieve the full column specification for this data.\n",
      "\u001b[36mℹ\u001b[39m Specify the column types or set \u001b[30m\u001b[47m\u001b[30m\u001b[47m`show_col_types = FALSE`\u001b[47m\u001b[30m\u001b[49m\u001b[39m to quiet this message.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 6 × 21</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>...1</th><th scope=col>PDXSource</th><th scope=col>Contributor</th><th scope=col>ContributorPDX.ID</th><th scope=col>PDMR.Patient.ID</th><th scope=col>Gender</th><th scope=col>CTEP.SDCCode</th><th scope=col>CTEP.SDCDescription</th><th scope=col>DiagnosisSubtype</th><th scope=col>Disease.BodyLocation</th><th scope=col>⋯</th><th scope=col>Date.ofDiagnosis</th><th scope=col>Has.KnownMetastaticDisease</th><th scope=col>Grade.StageInformation</th><th scope=col>PatientNotes</th><th scope=col>Molecular.andIHC.Data</th><th scope=col>Has.Smoked100.Cigarettes</th><th scope=col>Race</th><th scope=col>Ethnicity</th><th scope=col>AdditionalMedicalHistory</th><th scope=col>Submission</th></tr>\n",
       "\t<tr><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>⋯</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dttm&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>1</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8174</td><td>K42829</td><td>Female</td><td>10009951</td><td>Adenocarcinoma - colon</td><td><span style=white-space:pre-wrap>adenocarcinoma of sigmoid colon                                   </span></td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>42790</td><td><span style=white-space:pre-wrap>Yes         </span></td><td><span style=white-space:pre-wrap>Stage             </span></td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis, omentum, Chest wall (left), Lymph node (left axillary)</td><td><span style=white-space:pre-wrap>APC c.4037C&gt;G p.S1346*; FBXW7 c.832C&gt;T p.R278*; KRAS c.38G&gt;A p.G13D; TP53 c.427G&gt;A p.V143M                              </span></td><td>No </td><td><span style=white-space:pre-wrap>White       </span></td><td>Not Hispanic or Latino</td><td><span style=white-space:pre-wrap>-                                                                                                                     </span></td><td>2021-09-02</td></tr>\n",
       "\t<tr><td>2</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8175</td><td>K30337</td><td>Female</td><td>10009951</td><td>Adenocarcinoma - colon</td><td>adenocarcinoma                                                    </td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>42500</td><td>Yes         </td><td>Stage             </td><td>Tumor Grade/Stage: Stage IV, poorly differentiated Location of known metastases: Peritoneum, Liver                      </td><td>KRAS/NRAS WT,BRAF mutated, MSI Stable                                                                                   </td><td>No </td><td>White       </td><td>Hispanic or Latino    </td><td>Family h/o: 2nd degree relative, Uterine cancer                                                                       </td><td>2018-12-19</td></tr>\n",
       "\t<tr><td>3</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8176</td><td>K45526</td><td>Female</td><td>10009951</td><td>Adenocarcinoma - colon</td><td>Lynch syndrome; mucinous and signet ring cell adenocarcinoma      </td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>42132</td><td>Not Reported</td><td>TNM (Pathological)</td><td>Tumor Grade/Stage:  pT1bpN0pM0, poorly differentiated Location of known metastases: Liver, Abdomen                      </td><td>Germline heterozygous MSH2 c388_389del variant (deleterious) Lynch syndrome, MSI-high; KRAS-G12D; Loss of MSH2 and MSH6;</td><td>Yes</td><td>White       </td><td>Hispanic or Latino    </td><td>Family History: 1st degree relative, GI cancer involving esophagus, liver, bile duct, stomach, pancreas, colon, rectum</td><td>2018-12-19</td></tr>\n",
       "\t<tr><td>4</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8182</td><td>K75566</td><td>Female</td><td>10009951</td><td>Adenocarcinoma - colon</td><td>poorly differentiated mucinous and signet ring cell adenocarcinoma</td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>42644</td><td>Yes         </td><td>Stage, TNM        </td><td>Tumor Grade/Stage: Stage III T4N2M0 Location of known metastases: Liver                                                 </td><td>-                                                                                                                       </td><td>No </td><td>White       </td><td>Hispanic or Latino    </td><td>-                                                                                                                     </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td>5</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8183</td><td>K83548</td><td>Male  </td><td>10009951</td><td>Adenocarcinoma - colon</td><td>adenocarcinoma                                                    </td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>42184</td><td>Yes         </td><td>Stage             </td><td>Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases:  Liver, Duodenum, Pelvis          </td><td>MSI-Stable; BRAF mutant; KRAS wild type                                                                                 </td><td>Yes</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                     </td><td>2018-12-19</td></tr>\n",
       "\t<tr><td>6</td><td>PDXNet Consortium Members</td><td>MDACC</td><td>B8207</td><td>K49395</td><td>Male  </td><td>10009951</td><td>Adenocarcinoma - colon</td><td>Sigmoid                                                           </td><td>Digestive/Gastrointestinal</td><td>⋯</td><td>41537</td><td>Yes         </td><td>Stage, TNM        </td><td>Tumor Grade/Stage: Stage IVB, TxNxM1b, Moderately differentiated  Location of known metastases: Liver, Lung             </td><td>Mutations present in: MDM4, NOTCH1, RB1, TP53, APC                                                                      </td><td>Yes</td><td>White       </td><td>Not Hispanic or Latino</td><td>No family history of cancer                                                                                           </td><td>2021-09-02</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 6 × 21\n",
       "\\begin{tabular}{lllllllllllllllllllll}\n",
       " ...1 & PDXSource & Contributor & ContributorPDX.ID & PDMR.Patient.ID & Gender & CTEP.SDCCode & CTEP.SDCDescription & DiagnosisSubtype & Disease.BodyLocation & ⋯ & Date.ofDiagnosis & Has.KnownMetastaticDisease & Grade.StageInformation & PatientNotes & Molecular.andIHC.Data & Has.Smoked100.Cigarettes & Race & Ethnicity & AdditionalMedicalHistory & Submission\\\\\n",
       " <dbl> & <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & ⋯ & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <dttm>\\\\\n",
       "\\hline\n",
       "\t 1 & PDXNet Consortium Members & MDACC & B8174 & K42829 & Female & 10009951 & Adenocarcinoma - colon & adenocarcinoma of sigmoid colon                                    & Digestive/Gastrointestinal & ⋯ & 42790 & Yes          & Stage              & Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis, omentum, Chest wall (left), Lymph node (left axillary) & APC c.4037C>G p.S1346*; FBXW7 c.832C>T p.R278*; KRAS c.38G>A p.G13D; TP53 c.427G>A p.V143M                               & No  & White        & Not Hispanic or Latino & -                                                                                                                      & 2021-09-02\\\\\n",
       "\t 2 & PDXNet Consortium Members & MDACC & B8175 & K30337 & Female & 10009951 & Adenocarcinoma - colon & adenocarcinoma                                                     & Digestive/Gastrointestinal & ⋯ & 42500 & Yes          & Stage              & Tumor Grade/Stage: Stage IV, poorly differentiated Location of known metastases: Peritoneum, Liver                       & KRAS/NRAS WT,BRAF mutated, MSI Stable                                                                                    & No  & White        & Hispanic or Latino     & Family h/o: 2nd degree relative, Uterine cancer                                                                        & 2018-12-19\\\\\n",
       "\t 3 & PDXNet Consortium Members & MDACC & B8176 & K45526 & Female & 10009951 & Adenocarcinoma - colon & Lynch syndrome; mucinous and signet ring cell adenocarcinoma       & Digestive/Gastrointestinal & ⋯ & 42132 & Not Reported & TNM (Pathological) & Tumor Grade/Stage:  pT1bpN0pM0, poorly differentiated Location of known metastases: Liver, Abdomen                       & Germline heterozygous MSH2 c388\\_389del variant (deleterious) Lynch syndrome, MSI-high; KRAS-G12D; Loss of MSH2 and MSH6; & Yes & White        & Hispanic or Latino     & Family History: 1st degree relative, GI cancer involving esophagus, liver, bile duct, stomach, pancreas, colon, rectum & 2018-12-19\\\\\n",
       "\t 4 & PDXNet Consortium Members & MDACC & B8182 & K75566 & Female & 10009951 & Adenocarcinoma - colon & poorly differentiated mucinous and signet ring cell adenocarcinoma & Digestive/Gastrointestinal & ⋯ & 42644 & Yes          & Stage, TNM         & Tumor Grade/Stage: Stage III T4N2M0 Location of known metastases: Liver                                                  & -                                                                                                                        & No  & White        & Hispanic or Latino     & -                                                                                                                      & 2021-09-02\\\\\n",
       "\t 5 & PDXNet Consortium Members & MDACC & B8183 & K83548 & Male   & 10009951 & Adenocarcinoma - colon & adenocarcinoma                                                     & Digestive/Gastrointestinal & ⋯ & 42184 & Yes          & Stage              & Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases:  Liver, Duodenum, Pelvis           & MSI-Stable; BRAF mutant; KRAS wild type                                                                                  & Yes & Not Provided & Not Provided           & -                                                                                                                      & 2018-12-19\\\\\n",
       "\t 6 & PDXNet Consortium Members & MDACC & B8207 & K49395 & Male   & 10009951 & Adenocarcinoma - colon & Sigmoid                                                            & Digestive/Gastrointestinal & ⋯ & 41537 & Yes          & Stage, TNM         & Tumor Grade/Stage: Stage IVB, TxNxM1b, Moderately differentiated  Location of known metastases: Liver, Lung              & Mutations present in: MDM4, NOTCH1, RB1, TP53, APC                                                                       & Yes & White        & Not Hispanic or Latino & No family history of cancer                                                                                            & 2021-09-02\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 6 × 21\n",
       "\n",
       "| ...1 &lt;dbl&gt; | PDXSource &lt;chr&gt; | Contributor &lt;chr&gt; | ContributorPDX.ID &lt;chr&gt; | PDMR.Patient.ID &lt;chr&gt; | Gender &lt;chr&gt; | CTEP.SDCCode &lt;dbl&gt; | CTEP.SDCDescription &lt;chr&gt; | DiagnosisSubtype &lt;chr&gt; | Disease.BodyLocation &lt;chr&gt; | ⋯ ⋯ | Date.ofDiagnosis &lt;chr&gt; | Has.KnownMetastaticDisease &lt;chr&gt; | Grade.StageInformation &lt;chr&gt; | PatientNotes &lt;chr&gt; | Molecular.andIHC.Data &lt;chr&gt; | Has.Smoked100.Cigarettes &lt;chr&gt; | Race &lt;chr&gt; | Ethnicity &lt;chr&gt; | AdditionalMedicalHistory &lt;chr&gt; | Submission &lt;dttm&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 1 | PDXNet Consortium Members | MDACC | B8174 | K42829 | Female | 10009951 | Adenocarcinoma - colon | adenocarcinoma of sigmoid colon                                    | Digestive/Gastrointestinal | ⋯ | 42790 | Yes          | Stage              | Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis, omentum, Chest wall (left), Lymph node (left axillary) | APC c.4037C&gt;G p.S1346*; FBXW7 c.832C&gt;T p.R278*; KRAS c.38G&gt;A p.G13D; TP53 c.427G&gt;A p.V143M                               | No  | White        | Not Hispanic or Latino | -                                                                                                                      | 2021-09-02 |\n",
       "| 2 | PDXNet Consortium Members | MDACC | B8175 | K30337 | Female | 10009951 | Adenocarcinoma - colon | adenocarcinoma                                                     | Digestive/Gastrointestinal | ⋯ | 42500 | Yes          | Stage              | Tumor Grade/Stage: Stage IV, poorly differentiated Location of known metastases: Peritoneum, Liver                       | KRAS/NRAS WT,BRAF mutated, MSI Stable                                                                                    | No  | White        | Hispanic or Latino     | Family h/o: 2nd degree relative, Uterine cancer                                                                        | 2018-12-19 |\n",
       "| 3 | PDXNet Consortium Members | MDACC | B8176 | K45526 | Female | 10009951 | Adenocarcinoma - colon | Lynch syndrome; mucinous and signet ring cell adenocarcinoma       | Digestive/Gastrointestinal | ⋯ | 42132 | Not Reported | TNM (Pathological) | Tumor Grade/Stage:  pT1bpN0pM0, poorly differentiated Location of known metastases: Liver, Abdomen                       | Germline heterozygous MSH2 c388_389del variant (deleterious) Lynch syndrome, MSI-high; KRAS-G12D; Loss of MSH2 and MSH6; | Yes | White        | Hispanic or Latino     | Family History: 1st degree relative, GI cancer involving esophagus, liver, bile duct, stomach, pancreas, colon, rectum | 2018-12-19 |\n",
       "| 4 | PDXNet Consortium Members | MDACC | B8182 | K75566 | Female | 10009951 | Adenocarcinoma - colon | poorly differentiated mucinous and signet ring cell adenocarcinoma | Digestive/Gastrointestinal | ⋯ | 42644 | Yes          | Stage, TNM         | Tumor Grade/Stage: Stage III T4N2M0 Location of known metastases: Liver                                                  | -                                                                                                                        | No  | White        | Hispanic or Latino     | -                                                                                                                      | 2021-09-02 |\n",
       "| 5 | PDXNet Consortium Members | MDACC | B8183 | K83548 | Male   | 10009951 | Adenocarcinoma - colon | adenocarcinoma                                                     | Digestive/Gastrointestinal | ⋯ | 42184 | Yes          | Stage              | Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases:  Liver, Duodenum, Pelvis           | MSI-Stable; BRAF mutant; KRAS wild type                                                                                  | Yes | Not Provided | Not Provided           | -                                                                                                                      | 2018-12-19 |\n",
       "| 6 | PDXNet Consortium Members | MDACC | B8207 | K49395 | Male   | 10009951 | Adenocarcinoma - colon | Sigmoid                                                            | Digestive/Gastrointestinal | ⋯ | 41537 | Yes          | Stage, TNM         | Tumor Grade/Stage: Stage IVB, TxNxM1b, Moderately differentiated  Location of known metastases: Liver, Lung              | Mutations present in: MDM4, NOTCH1, RB1, TP53, APC                                                                       | Yes | White        | Not Hispanic or Latino | No family history of cancer                                                                                            | 2021-09-02 |\n",
       "\n"
      ],
      "text/plain": [
       "  ...1 PDXSource                 Contributor ContributorPDX.ID PDMR.Patient.ID\n",
       "1 1    PDXNet Consortium Members MDACC       B8174             K42829         \n",
       "2 2    PDXNet Consortium Members MDACC       B8175             K30337         \n",
       "3 3    PDXNet Consortium Members MDACC       B8176             K45526         \n",
       "4 4    PDXNet Consortium Members MDACC       B8182             K75566         \n",
       "5 5    PDXNet Consortium Members MDACC       B8183             K83548         \n",
       "6 6    PDXNet Consortium Members MDACC       B8207             K49395         \n",
       "  Gender CTEP.SDCCode CTEP.SDCDescription   \n",
       "1 Female 10009951     Adenocarcinoma - colon\n",
       "2 Female 10009951     Adenocarcinoma - colon\n",
       "3 Female 10009951     Adenocarcinoma - colon\n",
       "4 Female 10009951     Adenocarcinoma - colon\n",
       "5 Male   10009951     Adenocarcinoma - colon\n",
       "6 Male   10009951     Adenocarcinoma - colon\n",
       "  DiagnosisSubtype                                                  \n",
       "1 adenocarcinoma of sigmoid colon                                   \n",
       "2 adenocarcinoma                                                    \n",
       "3 Lynch syndrome; mucinous and signet ring cell adenocarcinoma      \n",
       "4 poorly differentiated mucinous and signet ring cell adenocarcinoma\n",
       "5 adenocarcinoma                                                    \n",
       "6 Sigmoid                                                           \n",
       "  Disease.BodyLocation       ⋯ Date.ofDiagnosis Has.KnownMetastaticDisease\n",
       "1 Digestive/Gastrointestinal ⋯ 42790            Yes                       \n",
       "2 Digestive/Gastrointestinal ⋯ 42500            Yes                       \n",
       "3 Digestive/Gastrointestinal ⋯ 42132            Not Reported              \n",
       "4 Digestive/Gastrointestinal ⋯ 42644            Yes                       \n",
       "5 Digestive/Gastrointestinal ⋯ 42184            Yes                       \n",
       "6 Digestive/Gastrointestinal ⋯ 41537            Yes                       \n",
       "  Grade.StageInformation\n",
       "1 Stage                 \n",
       "2 Stage                 \n",
       "3 TNM (Pathological)    \n",
       "4 Stage, TNM            \n",
       "5 Stage                 \n",
       "6 Stage, TNM            \n",
       "  PatientNotes                                                                                                            \n",
       "1 Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis, omentum, Chest wall (left), Lymph node (left axillary)\n",
       "2 Tumor Grade/Stage: Stage IV, poorly differentiated Location of known metastases: Peritoneum, Liver                      \n",
       "3 Tumor Grade/Stage:  pT1bpN0pM0, poorly differentiated Location of known metastases: Liver, Abdomen                      \n",
       "4 Tumor Grade/Stage: Stage III T4N2M0 Location of known metastases: Liver                                                 \n",
       "5 Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases:  Liver, Duodenum, Pelvis          \n",
       "6 Tumor Grade/Stage: Stage IVB, TxNxM1b, Moderately differentiated  Location of known metastases: Liver, Lung             \n",
       "  Molecular.andIHC.Data                                                                                                   \n",
       "1 APC c.4037C>G p.S1346*; FBXW7 c.832C>T p.R278*; KRAS c.38G>A p.G13D; TP53 c.427G>A p.V143M                              \n",
       "2 KRAS/NRAS WT,BRAF mutated, MSI Stable                                                                                   \n",
       "3 Germline heterozygous MSH2 c388_389del variant (deleterious) Lynch syndrome, MSI-high; KRAS-G12D; Loss of MSH2 and MSH6;\n",
       "4 -                                                                                                                       \n",
       "5 MSI-Stable; BRAF mutant; KRAS wild type                                                                                 \n",
       "6 Mutations present in: MDM4, NOTCH1, RB1, TP53, APC                                                                      \n",
       "  Has.Smoked100.Cigarettes Race         Ethnicity             \n",
       "1 No                       White        Not Hispanic or Latino\n",
       "2 No                       White        Hispanic or Latino    \n",
       "3 Yes                      White        Hispanic or Latino    \n",
       "4 No                       White        Hispanic or Latino    \n",
       "5 Yes                      Not Provided Not Provided          \n",
       "6 Yes                      White        Not Hispanic or Latino\n",
       "  AdditionalMedicalHistory                                                                                              \n",
       "1 -                                                                                                                     \n",
       "2 Family h/o: 2nd degree relative, Uterine cancer                                                                       \n",
       "3 Family History: 1st degree relative, GI cancer involving esophagus, liver, bile duct, stomach, pancreas, colon, rectum\n",
       "4 -                                                                                                                     \n",
       "5 -                                                                                                                     \n",
       "6 No family history of cancer                                                                                           \n",
       "  Submission\n",
       "1 2021-09-02\n",
       "2 2018-12-19\n",
       "3 2018-12-19\n",
       "4 2021-09-02\n",
       "5 2018-12-19\n",
       "6 2021-09-02"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pdtc_models <- read_csv('2022-02-09_pdxnet_portal_pdtc_models.csv')\n",
    "\n",
    "head(pdtc_models)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8d405670-67f2-4524-88dd-1db10dd1b8d0",
   "metadata": {},
   "source": [
    "### Edit the HCI models to match the correct formatting\n",
    "BCM's are all already in the correct format."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "7a8181f6-7cf0-429c-9b14-e51f136e5b21",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A spec_tbl_df: 44 × 21</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>...1</th><th scope=col>PDXSource</th><th scope=col>Contributor</th><th scope=col>ContributorPDX.ID</th><th scope=col>PDMR.Patient.ID</th><th scope=col>Gender</th><th scope=col>CTEP.SDCCode</th><th scope=col>CTEP.SDCDescription</th><th scope=col>DiagnosisSubtype</th><th scope=col>Disease.BodyLocation</th><th scope=col>⋯</th><th scope=col>Date.ofDiagnosis</th><th scope=col>Has.KnownMetastaticDisease</th><th scope=col>Grade.StageInformation</th><th scope=col>PatientNotes</th><th scope=col>Molecular.andIHC.Data</th><th scope=col>Has.Smoked100.Cigarettes</th><th scope=col>Race</th><th scope=col>Ethnicity</th><th scope=col>AdditionalMedicalHistory</th><th scope=col>Submission</th></tr>\n",
       "\t<tr><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>⋯</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dttm&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td> 68</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-004          </td><td>K92478</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>39995</td><td>Not Reported</td><td>None Provided    </td><td>Tumor Grade/Stage: Stage IIA, Grade III, Poorly differentiated                                                                                            </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Hispanic or Latino    </td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 69</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-008          </td><td>K88751</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>-                                                         </td><td>Breast</td><td>⋯</td><td>39083</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Pleura                                                                                          </td><td>ER-, PR-, Her2+                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 70</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-014          </td><td>K39284</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, Infiltrating lobular adenocarcinoma                 </td><td>Breast</td><td>⋯</td><td>39904</td><td>Yes         </td><td>Grade, Stage     </td><td>Tumor Grade/Stage: Stage IV, Grade II Location of known metastases: Bone, Pleura                                                                          </td><td>ER-, PR-, HER2-; Her2 IHC (2+); Her2 not amplified (FISH)       </td><td>No          </td><td>White       </td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 71</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-017          </td><td>K18605</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>ductal                                                    </td><td>Breast</td><td>⋯</td><td>41153</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: Brain, bone, lung                                                                                                           </td><td>ER+, PR+, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 72</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-018          </td><td>K80651</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Invasive lobular carcinoma with focal signet ring features</td><td>Breast</td><td>⋯</td><td>37012</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Bone, Ovary                                                                              </td><td>ER+, PR-, Her2-                                                 </td><td>No          </td><td>Not Provided</td><td>Not Provided          </td><td>Disease Progression: Invasive breast carcinoma, Stage IIIA (2001); Invasive lobular carcinoma, Stage IV (2003)                                                                                                               </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 73</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-019          </td><td>K18234</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, IDC with apocrine features                          </td><td>Breast</td><td>⋯</td><td>41456</td><td>Not Reported</td><td>None Provided    </td><td>Tumor Stage/Grade: poorly differentiated                                                                                                                  </td><td>ER- (1%), PR- (1%), Her2-                                       </td><td>Not Provided</td><td>Not Provided</td><td>Hispanic or Latino    </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-07</td></tr>\n",
       "\t<tr><td> 74</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-023          </td><td>K65121</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>41640</td><td>Yes         </td><td>None Provided    </td><td>Tumor Grade/Stage: Stage IIA, Grade II, Poorly differentiated Location of known metastases: Brain, Lung, Bone                                             </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 75</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-028LV        </td><td>K71592</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, adenocarcinoma                                      </td><td>Breast</td><td>⋯</td><td>40513</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: bone, pleura, brain                                                                             </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>White       </td><td>Not Hispanic or Latino</td><td>History of: ER+ (75%), PR-, Her2- in primary tumor and ER-, PR-, Her2+ in bone metastases; reported history of ER+, PR+, Her2- breast cancer micropapillary type with apocrine features                                      </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 76</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-031 (153-M)  </td><td>K61826</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, lobular                                             </td><td>Breast</td><td>⋯</td><td>39845</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                               </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 77</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-031OV (305-X)</td><td>K61826</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, lobular                                             </td><td>Breast</td><td>⋯</td><td>39845</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                               </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 78</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-032 (231-R)  </td><td>K07497</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>IDC with apocrine and micropapillary features.            </td><td>Breast</td><td>⋯</td><td>42186</td><td>Yes         </td><td>Grade, Stage     </td><td>Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                  </td><td>ER+, PR+, Her2+                                                 </td><td>Yes         </td><td>White       </td><td>Not Hispanic or Latino</td><td>DCIS is also present, cribform type, high grade                                                                                                                                                                              </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 79</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-032EI (152-X)</td><td>K07497</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>IDC with apocrine and micropapillary features.            </td><td>Breast</td><td>⋯</td><td>42186</td><td>Yes         </td><td>Grade, Stage     </td><td>Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                  </td><td>ER+, PR+, Her2+                                                 </td><td>Yes         </td><td>White       </td><td>Not Hispanic or Latino</td><td>DCIS is also present, cribform type, high grade                                                                                                                                                                              </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 80</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-037          </td><td>K60344</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>38353</td><td>Yes         </td><td>Stage            </td><td>Recurrence at primary site Tumor Grade/Stage: Stage IIIA Location of known metastases: Femur, pleura                                                      </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 invasive ductal breast cancer. Recurrence: (2016) ER-, PR-, Her2+ (3+) Grade 2 IDC                                                                                  </td><td>2019-05-21</td></tr>\n",
       "\t<tr><td> 81</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-040 (305-R)  </td><td>K12432</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>IDC                                                       </td><td>Breast</td><td>⋯</td><td>38718</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                        </td><td>ER+, PR+, HER2+                                                 </td><td>Yes         </td><td>White       </td><td>Not Hispanic or Latino</td><td>History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+</td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 82</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-040EI (244-X)</td><td>K12432</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>IDC                                                       </td><td>Breast</td><td>⋯</td><td>38718</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                        </td><td>ER+, PR+, HER2+                                                 </td><td>Yes         </td><td>White       </td><td>Not Hispanic or Latino</td><td>History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+</td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 83</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-041          </td><td>K96261</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, metaplastic                                         </td><td>Breast</td><td>⋯</td><td>43101</td><td>Not Reported</td><td>None Provided    </td><td>-                                                                                                                                                         </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 84</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-042          </td><td>K74601</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>42736</td><td>Not Reported</td><td>None Provided    </td><td>-                                                                                                                                                         </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 85</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-043 (060-T)  </td><td>K34576</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>43160</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: liver, bone, ascites                                                                                                        </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 86</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-044 (182-R)  </td><td>K29053</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>invasive ductal carcinoma                                 </td><td>Breast</td><td>⋯</td><td>41944</td><td>Yes         </td><td>None Provided    </td><td>Location of metastases: Bone, pleura                                                                                                                      </td><td>ER+, PR+, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 87</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-044EI (152-X)</td><td>K29053</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>invasive ductal carcinoma                                 </td><td>Breast</td><td>⋯</td><td>41944</td><td>Yes         </td><td>None Provided    </td><td>Location of metastases: Bone, pleura                                                                                                                      </td><td>ER+, PR+, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 88</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-045          </td><td>K88866</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>43374</td><td>Not Reported</td><td>None Provided    </td><td>-                                                                                                                                                         </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 89</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-046          </td><td>K31473</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>43405</td><td>Not Reported</td><td>None Provided    </td><td>-                                                                                                                                                         </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 90</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-049          </td><td>K64320</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Invasive ductal carcinoma                                 </td><td>Breast</td><td>⋯</td><td>43101</td><td>Not Reported</td><td>None Provided    </td><td>-                                                                                                                                                         </td><td>ER+, PR+, Her2-                                                 </td><td>Yes         </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 91</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-051 (244-M)  </td><td>K34576</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>43160</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: liver, bone, ascites                                                                                                        </td><td>ER-, PR-, Her2-                                                 </td><td>No          </td><td>White       </td><td>Not Hispanic or Latino</td><td>-                                                                                                                                                                                                                            </td><td>2021-09-02</td></tr>\n",
       "\t<tr><td> 92</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-001          </td><td>K55119</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC. IDC, papillary architecture                         </td><td>Breast</td><td>⋯</td><td>39083</td><td>Yes         </td><td>Grade, Stage     </td><td>Tumor Grade/Stage: Stage 4, Grade III Location of known metastases: Lung                                                                                  </td><td>-                                                               </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-11</td></tr>\n",
       "\t<tr><td> 93</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-002          </td><td>K50745</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>39845</td><td>Yes         </td><td>Grade            </td><td>Tumor Grade/Stage:  Grade III Location of known metastases: Lymph node                                                                                    </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-11</td></tr>\n",
       "\t<tr><td> 94</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-005 (336-M)  </td><td>K42072</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Adenocarcinoma                                            </td><td>Breast</td><td>⋯</td><td>36951</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                              </td><td>ER+, PR+, HER2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-11</td></tr>\n",
       "\t<tr><td> 95</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-007 (274-M)  </td><td>K42072</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Adenocarcinoma                                            </td><td>Breast</td><td>⋯</td><td>36951</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                              </td><td>ER+, PR+, HER2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-11</td></tr>\n",
       "\t<tr><td> 96</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-009          </td><td>K93541</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, apocrine features                                   </td><td>Breast</td><td>⋯</td><td>31048</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pancreas, peritoneum                                                                </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-16</td></tr>\n",
       "\t<tr><td> 97</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-010          </td><td>K16669</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>39083</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Lung Location of known metastases: Lung, Pleura                                                                                        </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-16</td></tr>\n",
       "\t<tr><td> 98</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-011          </td><td>K91478</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>IDC                                                       </td><td>Breast</td><td>⋯</td><td>39326</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: lymph node, pleura                                                                              </td><td>ER+, PR+, HER2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-11</td></tr>\n",
       "\t<tr><td> 99</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-012          </td><td>K40892</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Adenocarcinoma                                            </td><td>Breast</td><td>⋯</td><td>36526</td><td>Yes         </td><td>None Provided    </td><td>Location of known metastases: Lymph node, pericardium                                                                                                     </td><td>ER-, PR-, Her2 not reported                                     </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Biomarker assessment 2 years prior showed ER-/PR-/HER2+ disease. HER2 status was not re-tested on the pleural effusion sample used to make the PDX.                                                                          </td><td>2019-06-12</td></tr>\n",
       "\t<tr><td>100</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-013 (M1)     </td><td>K97960</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Invasive lobular carcinoma                                </td><td>Breast</td><td>⋯</td><td>37742</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                        </td><td>ER+, PR+, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-07</td></tr>\n",
       "\t<tr><td>101</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-013EI (M2)   </td><td>K97960</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>Invasive lobular carcinoma                                </td><td>Breast</td><td>⋯</td><td>37742</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                        </td><td>ER+, PR+, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-07</td></tr>\n",
       "\t<tr><td>102</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-015          </td><td>K90681</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>40148</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Brain                                                                                           </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-16</td></tr>\n",
       "\t<tr><td>103</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-016          </td><td>K17667</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>ductal                                                    </td><td>Breast</td><td>⋯</td><td>23163</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IIIb                                                                                                                             </td><td>BRCA germline mutation, 4184del4                                </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Patient history:2nd  breast cancer diagnosis but unclear if it is a recurrence or 2nd primary. Family is BRCA1+                                                                                                              </td><td>2019-05-16</td></tr>\n",
       "\t<tr><td>104</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-025          </td><td>K42933</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, invasive with squamous differentiation (metaplastic)</td><td>Breast</td><td>⋯</td><td>41275</td><td>Yes         </td><td>Grade, Stage     </td><td>Tumor Grade/Stage: Stage IV, Grade 3 Location of known metastases: SVC lymph node (LN), posterior cervical LN, anterosuperior mediastinum LN, neck, chest.</td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-12</td></tr>\n",
       "\t<tr><td>105</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-027          </td><td>K11172</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, IDC                                                 </td><td>Breast</td><td>⋯</td><td>42614</td><td>Yes         </td><td>Grade, Stage, TNM</td><td>Tumor Grade/Stage: Grade 3, Stage IIIC, T3N3M0 Location of known metastases: Lymph node, bone, liver                                                      </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-06-12</td></tr>\n",
       "\t<tr><td>106</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-028          </td><td>K53784</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, IDC                                                 </td><td>Breast</td><td>⋯</td><td>40513</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lung, Ovary, Liver, Brain                                                                 </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Patient history shows mixed biomarker information: Primary tumor: ER+ (75%), PR-, HER2-;  Bone metastasis: ER-, PR-, HER2+; Metastatic effusion: ER-, PR-, HER2- (TNBC).                                                     </td><td>2019-05-07</td></tr>\n",
       "\t<tr><td>107</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-030          </td><td>K37516</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, IDC                                                 </td><td>Breast</td><td>⋯</td><td>36161</td><td>Not Reported</td><td>Grade, Stage, TNM</td><td>Recurrence: primary site Tumor Grade/Stage: Stage IIA, Grade 2 (poorly differentiated), T3N3Mx                                                            </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Original diagnosis 1999, recurrence 2003, recurrence 2010                                                                                                                                                                    </td><td>2019-05-07</td></tr>\n",
       "\t<tr><td>108</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-033 (244-R)  </td><td>K82491</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, adenocarcinoma                                      </td><td>Breast</td><td>⋯</td><td>38718</td><td>Yes         </td><td>Grade, Stage     </td><td>Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung                                                       </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS                                                                                                                       </td><td>2019-05-21</td></tr>\n",
       "\t<tr><td>110</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-036          </td><td>K73638</td><td>Female</td><td>10053130</td><td>Cystosarcoma phylloides - breast</td><td>TNBC                                                      </td><td>Breast</td><td>⋯</td><td>41030</td><td>Not Reported</td><td>None Provided    </td><td>Recurrence at primary site                                                                                                                                </td><td>ER-, PR-, Her2-                                                 </td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>-                                                                                                                                                                                                                            </td><td>2019-05-16</td></tr>\n",
       "\t<tr><td>111</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-038 (121-R)  </td><td>K23558</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>38353</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                   </td><td>ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)</td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                     </td><td>2019-05-21</td></tr>\n",
       "\t<tr><td>112</td><td>PDXNet Consortium Members</td><td>HCI</td><td>HCI-039 (121-M)  </td><td>K23558</td><td>Female</td><td>10006190</td><td>Invasive breast carcinoma       </td><td>TNBC, ductal                                              </td><td>Breast</td><td>⋯</td><td>38353</td><td>Yes         </td><td>Stage            </td><td>Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                   </td><td>ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)</td><td>Not Provided</td><td>Not Provided</td><td>Not Provided          </td><td>Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                     </td><td>2019-05-21</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A spec\\_tbl\\_df: 44 × 21\n",
       "\\begin{tabular}{lllllllllllllllllllll}\n",
       " ...1 & PDXSource & Contributor & ContributorPDX.ID & PDMR.Patient.ID & Gender & CTEP.SDCCode & CTEP.SDCDescription & DiagnosisSubtype & Disease.BodyLocation & ⋯ & Date.ofDiagnosis & Has.KnownMetastaticDisease & Grade.StageInformation & PatientNotes & Molecular.andIHC.Data & Has.Smoked100.Cigarettes & Race & Ethnicity & AdditionalMedicalHistory & Submission\\\\\n",
       " <dbl> & <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & ⋯ & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <dttm>\\\\\n",
       "\\hline\n",
       "\t  68 & PDXNet Consortium Members & HCI & HCI-004           & K92478 & Female & 10006190 & Invasive breast carcinoma        & TNBC                                                       & Breast & ⋯ & 39995 & Not Reported & None Provided     & Tumor Grade/Stage: Stage IIA, Grade III, Poorly differentiated                                                                                             & ER-, PR-, Her2-                                                  & No           & White        & Hispanic or Latino     & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  69 & PDXNet Consortium Members & HCI & HCI-008           & K88751 & Female & 10006190 & Invasive breast carcinoma        & -                                                          & Breast & ⋯ & 39083 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Pleura                                                                                           & ER-, PR-, Her2+                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  70 & PDXNet Consortium Members & HCI & HCI-014           & K39284 & Female & 10006190 & Invasive breast carcinoma        & TNBC, Infiltrating lobular adenocarcinoma                  & Breast & ⋯ & 39904 & Yes          & Grade, Stage      & Tumor Grade/Stage: Stage IV, Grade II Location of known metastases: Bone, Pleura                                                                           & ER-, PR-, HER2-; Her2 IHC (2+); Her2 not amplified (FISH)        & No           & White        & Not Provided           & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  71 & PDXNet Consortium Members & HCI & HCI-017           & K18605 & Female & 10006190 & Invasive breast carcinoma        & ductal                                                     & Breast & ⋯ & 41153 & Yes          & None Provided     & Location of known metastases: Brain, bone, lung                                                                                                            & ER+, PR+, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  72 & PDXNet Consortium Members & HCI & HCI-018           & K80651 & Female & 10006190 & Invasive breast carcinoma        & Invasive lobular carcinoma with focal signet ring features & Breast & ⋯ & 37012 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Bone, Ovary                                                                               & ER+, PR-, Her2-                                                  & No           & Not Provided & Not Provided           & Disease Progression: Invasive breast carcinoma, Stage IIIA (2001); Invasive lobular carcinoma, Stage IV (2003)                                                                                                                & 2021-09-02\\\\\n",
       "\t  73 & PDXNet Consortium Members & HCI & HCI-019           & K18234 & Female & 10006190 & Invasive breast carcinoma        & TNBC, IDC with apocrine features                           & Breast & ⋯ & 41456 & Not Reported & None Provided     & Tumor Stage/Grade: poorly differentiated                                                                                                                   & ER- (1\\%), PR- (1\\%), Her2-                                        & Not Provided & Not Provided & Hispanic or Latino     & -                                                                                                                                                                                                                             & 2019-05-07\\\\\n",
       "\t  74 & PDXNet Consortium Members & HCI & HCI-023           & K65121 & Female & 10006190 & Invasive breast carcinoma        & TNBC                                                       & Breast & ⋯ & 41640 & Yes          & None Provided     & Tumor Grade/Stage: Stage IIA, Grade II, Poorly differentiated Location of known metastases: Brain, Lung, Bone                                              & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  75 & PDXNet Consortium Members & HCI & HCI-028LV         & K71592 & Female & 10006190 & Invasive breast carcinoma        & TNBC, adenocarcinoma                                       & Breast & ⋯ & 40513 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: bone, pleura, brain                                                                              & ER-, PR-, Her2-                                                  & Not Provided & White        & Not Hispanic or Latino & History of: ER+ (75\\%), PR-, Her2- in primary tumor and ER-, PR-, Her2+ in bone metastases; reported history of ER+, PR+, Her2- breast cancer micropapillary type with apocrine features                                       & 2021-09-02\\\\\n",
       "\t  76 & PDXNet Consortium Members & HCI & HCI-031 (153-M)   & K61826 & Female & 10006190 & Invasive breast carcinoma        & TNBC, lobular                                              & Breast & ⋯ & 39845 & Yes          & None Provided     & Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                                & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  77 & PDXNet Consortium Members & HCI & HCI-031OV (305-X) & K61826 & Female & 10006190 & Invasive breast carcinoma        & TNBC, lobular                                              & Breast & ⋯ & 39845 & Yes          & None Provided     & Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                                & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  78 & PDXNet Consortium Members & HCI & HCI-032 (231-R)   & K07497 & Female & 10006190 & Invasive breast carcinoma        & IDC with apocrine and micropapillary features.             & Breast & ⋯ & 42186 & Yes          & Grade, Stage      & Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                   & ER+, PR+, Her2+                                                  & Yes          & White        & Not Hispanic or Latino & DCIS is also present, cribform type, high grade                                                                                                                                                                               & 2021-09-02\\\\\n",
       "\t  79 & PDXNet Consortium Members & HCI & HCI-032EI (152-X) & K07497 & Female & 10006190 & Invasive breast carcinoma        & IDC with apocrine and micropapillary features.             & Breast & ⋯ & 42186 & Yes          & Grade, Stage      & Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                   & ER+, PR+, Her2+                                                  & Yes          & White        & Not Hispanic or Latino & DCIS is also present, cribform type, high grade                                                                                                                                                                               & 2021-09-02\\\\\n",
       "\t  80 & PDXNet Consortium Members & HCI & HCI-037           & K60344 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 38353 & Yes          & Stage             & Recurrence at primary site Tumor Grade/Stage: Stage IIIA Location of known metastases: Femur, pleura                                                       & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 invasive ductal breast cancer. Recurrence: (2016) ER-, PR-, Her2+ (3+) Grade 2 IDC                                                                                   & 2019-05-21\\\\\n",
       "\t  81 & PDXNet Consortium Members & HCI & HCI-040 (305-R)   & K12432 & Female & 10006190 & Invasive breast carcinoma        & IDC                                                        & Breast & ⋯ & 38718 & Yes          & Stage             & Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                         & ER+, PR+, HER2+                                                  & Yes          & White        & Not Hispanic or Latino & History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+ & 2021-09-02\\\\\n",
       "\t  82 & PDXNet Consortium Members & HCI & HCI-040EI (244-X) & K12432 & Female & 10006190 & Invasive breast carcinoma        & IDC                                                        & Breast & ⋯ & 38718 & Yes          & Stage             & Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                         & ER+, PR+, HER2+                                                  & Yes          & White        & Not Hispanic or Latino & History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+ & 2021-09-02\\\\\n",
       "\t  83 & PDXNet Consortium Members & HCI & HCI-041           & K96261 & Female & 10006190 & Invasive breast carcinoma        & TNBC, metaplastic                                          & Breast & ⋯ & 43101 & Not Reported & None Provided     & -                                                                                                                                                          & ER-, PR-, Her2-                                                  & Not Provided & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  84 & PDXNet Consortium Members & HCI & HCI-042           & K74601 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 42736 & Not Reported & None Provided     & -                                                                                                                                                          & ER-, PR-, Her2-                                                  & Not Provided & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  85 & PDXNet Consortium Members & HCI & HCI-043 (060-T)   & K34576 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 43160 & Yes          & None Provided     & Location of known metastases: liver, bone, ascites                                                                                                         & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  86 & PDXNet Consortium Members & HCI & HCI-044 (182-R)   & K29053 & Female & 10006190 & Invasive breast carcinoma        & invasive ductal carcinoma                                  & Breast & ⋯ & 41944 & Yes          & None Provided     & Location of metastases: Bone, pleura                                                                                                                       & ER+, PR+, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  87 & PDXNet Consortium Members & HCI & HCI-044EI (152-X) & K29053 & Female & 10006190 & Invasive breast carcinoma        & invasive ductal carcinoma                                  & Breast & ⋯ & 41944 & Yes          & None Provided     & Location of metastases: Bone, pleura                                                                                                                       & ER+, PR+, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  88 & PDXNet Consortium Members & HCI & HCI-045           & K88866 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 43374 & Not Reported & None Provided     & -                                                                                                                                                          & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  89 & PDXNet Consortium Members & HCI & HCI-046           & K31473 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 43405 & Not Reported & None Provided     & -                                                                                                                                                          & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  90 & PDXNet Consortium Members & HCI & HCI-049           & K64320 & Female & 10006190 & Invasive breast carcinoma        & Invasive ductal carcinoma                                  & Breast & ⋯ & 43101 & Not Reported & None Provided     & -                                                                                                                                                          & ER+, PR+, Her2-                                                  & Yes          & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  91 & PDXNet Consortium Members & HCI & HCI-051 (244-M)   & K34576 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 43160 & Yes          & None Provided     & Location of known metastases: liver, bone, ascites                                                                                                         & ER-, PR-, Her2-                                                  & No           & White        & Not Hispanic or Latino & -                                                                                                                                                                                                                             & 2021-09-02\\\\\n",
       "\t  92 & PDXNet Consortium Members & HCI & HCI-001           & K55119 & Female & 10006190 & Invasive breast carcinoma        & TNBC. IDC, papillary architecture                          & Breast & ⋯ & 39083 & Yes          & Grade, Stage      & Tumor Grade/Stage: Stage 4, Grade III Location of known metastases: Lung                                                                                   & -                                                                & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-11\\\\\n",
       "\t  93 & PDXNet Consortium Members & HCI & HCI-002           & K50745 & Female & 10006190 & Invasive breast carcinoma        & TNBC                                                       & Breast & ⋯ & 39845 & Yes          & Grade             & Tumor Grade/Stage:  Grade III Location of known metastases: Lymph node                                                                                     & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-11\\\\\n",
       "\t  94 & PDXNet Consortium Members & HCI & HCI-005 (336-M)   & K42072 & Female & 10006190 & Invasive breast carcinoma        & Adenocarcinoma                                             & Breast & ⋯ & 36951 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                               & ER+, PR+, HER2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-11\\\\\n",
       "\t  95 & PDXNet Consortium Members & HCI & HCI-007 (274-M)   & K42072 & Female & 10006190 & Invasive breast carcinoma        & Adenocarcinoma                                             & Breast & ⋯ & 36951 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                               & ER+, PR+, HER2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-11\\\\\n",
       "\t  96 & PDXNet Consortium Members & HCI & HCI-009           & K93541 & Female & 10006190 & Invasive breast carcinoma        & TNBC, apocrine features                                    & Breast & ⋯ & 31048 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pancreas, peritoneum                                                                 & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-16\\\\\n",
       "\t  97 & PDXNet Consortium Members & HCI & HCI-010           & K16669 & Female & 10006190 & Invasive breast carcinoma        & TNBC                                                       & Breast & ⋯ & 39083 & Yes          & Stage             & Tumor Grade/Stage: Lung Location of known metastases: Lung, Pleura                                                                                         & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-16\\\\\n",
       "\t  98 & PDXNet Consortium Members & HCI & HCI-011           & K91478 & Female & 10006190 & Invasive breast carcinoma        & IDC                                                        & Breast & ⋯ & 39326 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: lymph node, pleura                                                                               & ER+, PR+, HER2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-11\\\\\n",
       "\t  99 & PDXNet Consortium Members & HCI & HCI-012           & K40892 & Female & 10006190 & Invasive breast carcinoma        & Adenocarcinoma                                             & Breast & ⋯ & 36526 & Yes          & None Provided     & Location of known metastases: Lymph node, pericardium                                                                                                      & ER-, PR-, Her2 not reported                                      & Not Provided & Not Provided & Not Provided           & Biomarker assessment 2 years prior showed ER-/PR-/HER2+ disease. HER2 status was not re-tested on the pleural effusion sample used to make the PDX.                                                                           & 2019-06-12\\\\\n",
       "\t 100 & PDXNet Consortium Members & HCI & HCI-013 (M1)      & K97960 & Female & 10006190 & Invasive breast carcinoma        & Invasive lobular carcinoma                                 & Breast & ⋯ & 37742 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                         & ER+, PR+, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-07\\\\\n",
       "\t 101 & PDXNet Consortium Members & HCI & HCI-013EI (M2)    & K97960 & Female & 10006190 & Invasive breast carcinoma        & Invasive lobular carcinoma                                 & Breast & ⋯ & 37742 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                         & ER+, PR+, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-07\\\\\n",
       "\t 102 & PDXNet Consortium Members & HCI & HCI-015           & K90681 & Female & 10006190 & Invasive breast carcinoma        & TNBC                                                       & Breast & ⋯ & 40148 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Brain                                                                                            & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-16\\\\\n",
       "\t 103 & PDXNet Consortium Members & HCI & HCI-016           & K17667 & Female & 10006190 & Invasive breast carcinoma        & ductal                                                     & Breast & ⋯ & 23163 & Yes          & Stage             & Tumor Grade/Stage: Stage IIIb                                                                                                                              & BRCA germline mutation, 4184del4                                 & Not Provided & Not Provided & Not Provided           & Patient history:2nd  breast cancer diagnosis but unclear if it is a recurrence or 2nd primary. Family is BRCA1+                                                                                                               & 2019-05-16\\\\\n",
       "\t 104 & PDXNet Consortium Members & HCI & HCI-025           & K42933 & Female & 10006190 & Invasive breast carcinoma        & TNBC, invasive with squamous differentiation (metaplastic) & Breast & ⋯ & 41275 & Yes          & Grade, Stage      & Tumor Grade/Stage: Stage IV, Grade 3 Location of known metastases: SVC lymph node (LN), posterior cervical LN, anterosuperior mediastinum LN, neck, chest. & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-12\\\\\n",
       "\t 105 & PDXNet Consortium Members & HCI & HCI-027           & K11172 & Female & 10006190 & Invasive breast carcinoma        & TNBC, IDC                                                  & Breast & ⋯ & 42614 & Yes          & Grade, Stage, TNM & Tumor Grade/Stage: Grade 3, Stage IIIC, T3N3M0 Location of known metastases: Lymph node, bone, liver                                                       & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-06-12\\\\\n",
       "\t 106 & PDXNet Consortium Members & HCI & HCI-028           & K53784 & Female & 10006190 & Invasive breast carcinoma        & TNBC, IDC                                                  & Breast & ⋯ & 40513 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lung, Ovary, Liver, Brain                                                                  & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & Patient history shows mixed biomarker information: Primary tumor: ER+ (75\\%), PR-, HER2-;  Bone metastasis: ER-, PR-, HER2+; Metastatic effusion: ER-, PR-, HER2- (TNBC).                                                      & 2019-05-07\\\\\n",
       "\t 107 & PDXNet Consortium Members & HCI & HCI-030           & K37516 & Female & 10006190 & Invasive breast carcinoma        & TNBC, IDC                                                  & Breast & ⋯ & 36161 & Not Reported & Grade, Stage, TNM & Recurrence: primary site Tumor Grade/Stage: Stage IIA, Grade 2 (poorly differentiated), T3N3Mx                                                             & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & Original diagnosis 1999, recurrence 2003, recurrence 2010                                                                                                                                                                     & 2019-05-07\\\\\n",
       "\t 108 & PDXNet Consortium Members & HCI & HCI-033 (244-R)   & K82491 & Female & 10006190 & Invasive breast carcinoma        & TNBC, adenocarcinoma                                       & Breast & ⋯ & 38718 & Yes          & Grade, Stage      & Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung                                                        & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS                                                                                                                        & 2019-05-21\\\\\n",
       "\t 110 & PDXNet Consortium Members & HCI & HCI-036           & K73638 & Female & 10053130 & Cystosarcoma phylloides - breast & TNBC                                                       & Breast & ⋯ & 41030 & Not Reported & None Provided     & Recurrence at primary site                                                                                                                                 & ER-, PR-, Her2-                                                  & Not Provided & Not Provided & Not Provided           & -                                                                                                                                                                                                                             & 2019-05-16\\\\\n",
       "\t 111 & PDXNet Consortium Members & HCI & HCI-038 (121-R)   & K23558 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 38353 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                    & ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance) & Not Provided & Not Provided & Not Provided           & Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                      & 2019-05-21\\\\\n",
       "\t 112 & PDXNet Consortium Members & HCI & HCI-039 (121-M)   & K23558 & Female & 10006190 & Invasive breast carcinoma        & TNBC, ductal                                               & Breast & ⋯ & 38353 & Yes          & Stage             & Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                    & ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance) & Not Provided & Not Provided & Not Provided           & Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                      & 2019-05-21\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A spec_tbl_df: 44 × 21\n",
       "\n",
       "| ...1 &lt;dbl&gt; | PDXSource &lt;chr&gt; | Contributor &lt;chr&gt; | ContributorPDX.ID &lt;chr&gt; | PDMR.Patient.ID &lt;chr&gt; | Gender &lt;chr&gt; | CTEP.SDCCode &lt;dbl&gt; | CTEP.SDCDescription &lt;chr&gt; | DiagnosisSubtype &lt;chr&gt; | Disease.BodyLocation &lt;chr&gt; | ⋯ ⋯ | Date.ofDiagnosis &lt;chr&gt; | Has.KnownMetastaticDisease &lt;chr&gt; | Grade.StageInformation &lt;chr&gt; | PatientNotes &lt;chr&gt; | Molecular.andIHC.Data &lt;chr&gt; | Has.Smoked100.Cigarettes &lt;chr&gt; | Race &lt;chr&gt; | Ethnicity &lt;chr&gt; | AdditionalMedicalHistory &lt;chr&gt; | Submission &lt;dttm&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "|  68 | PDXNet Consortium Members | HCI | HCI-004           | K92478 | Female | 10006190 | Invasive breast carcinoma        | TNBC                                                       | Breast | ⋯ | 39995 | Not Reported | None Provided     | Tumor Grade/Stage: Stage IIA, Grade III, Poorly differentiated                                                                                             | ER-, PR-, Her2-                                                  | No           | White        | Hispanic or Latino     | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  69 | PDXNet Consortium Members | HCI | HCI-008           | K88751 | Female | 10006190 | Invasive breast carcinoma        | -                                                          | Breast | ⋯ | 39083 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Pleura                                                                                           | ER-, PR-, Her2+                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  70 | PDXNet Consortium Members | HCI | HCI-014           | K39284 | Female | 10006190 | Invasive breast carcinoma        | TNBC, Infiltrating lobular adenocarcinoma                  | Breast | ⋯ | 39904 | Yes          | Grade, Stage      | Tumor Grade/Stage: Stage IV, Grade II Location of known metastases: Bone, Pleura                                                                           | ER-, PR-, HER2-; Her2 IHC (2+); Her2 not amplified (FISH)        | No           | White        | Not Provided           | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  71 | PDXNet Consortium Members | HCI | HCI-017           | K18605 | Female | 10006190 | Invasive breast carcinoma        | ductal                                                     | Breast | ⋯ | 41153 | Yes          | None Provided     | Location of known metastases: Brain, bone, lung                                                                                                            | ER+, PR+, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  72 | PDXNet Consortium Members | HCI | HCI-018           | K80651 | Female | 10006190 | Invasive breast carcinoma        | Invasive lobular carcinoma with focal signet ring features | Breast | ⋯ | 37012 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Bone, Ovary                                                                               | ER+, PR-, Her2-                                                  | No           | Not Provided | Not Provided           | Disease Progression: Invasive breast carcinoma, Stage IIIA (2001); Invasive lobular carcinoma, Stage IV (2003)                                                                                                                | 2021-09-02 |\n",
       "|  73 | PDXNet Consortium Members | HCI | HCI-019           | K18234 | Female | 10006190 | Invasive breast carcinoma        | TNBC, IDC with apocrine features                           | Breast | ⋯ | 41456 | Not Reported | None Provided     | Tumor Stage/Grade: poorly differentiated                                                                                                                   | ER- (1%), PR- (1%), Her2-                                        | Not Provided | Not Provided | Hispanic or Latino     | -                                                                                                                                                                                                                             | 2019-05-07 |\n",
       "|  74 | PDXNet Consortium Members | HCI | HCI-023           | K65121 | Female | 10006190 | Invasive breast carcinoma        | TNBC                                                       | Breast | ⋯ | 41640 | Yes          | None Provided     | Tumor Grade/Stage: Stage IIA, Grade II, Poorly differentiated Location of known metastases: Brain, Lung, Bone                                              | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  75 | PDXNet Consortium Members | HCI | HCI-028LV         | K71592 | Female | 10006190 | Invasive breast carcinoma        | TNBC, adenocarcinoma                                       | Breast | ⋯ | 40513 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: bone, pleura, brain                                                                              | ER-, PR-, Her2-                                                  | Not Provided | White        | Not Hispanic or Latino | History of: ER+ (75%), PR-, Her2- in primary tumor and ER-, PR-, Her2+ in bone metastases; reported history of ER+, PR+, Her2- breast cancer micropapillary type with apocrine features                                       | 2021-09-02 |\n",
       "|  76 | PDXNet Consortium Members | HCI | HCI-031 (153-M)   | K61826 | Female | 10006190 | Invasive breast carcinoma        | TNBC, lobular                                              | Breast | ⋯ | 39845 | Yes          | None Provided     | Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                                | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                             | 2021-09-02 |\n",
       "|  77 | PDXNet Consortium Members | HCI | HCI-031OV (305-X) | K61826 | Female | 10006190 | Invasive breast carcinoma        | TNBC, lobular                                              | Breast | ⋯ | 39845 | Yes          | None Provided     | Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                                | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                             | 2021-09-02 |\n",
       "|  78 | PDXNet Consortium Members | HCI | HCI-032 (231-R)   | K07497 | Female | 10006190 | Invasive breast carcinoma        | IDC with apocrine and micropapillary features.             | Breast | ⋯ | 42186 | Yes          | Grade, Stage      | Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                   | ER+, PR+, Her2+                                                  | Yes          | White        | Not Hispanic or Latino | DCIS is also present, cribform type, high grade                                                                                                                                                                               | 2021-09-02 |\n",
       "|  79 | PDXNet Consortium Members | HCI | HCI-032EI (152-X) | K07497 | Female | 10006190 | Invasive breast carcinoma        | IDC with apocrine and micropapillary features.             | Breast | ⋯ | 42186 | Yes          | Grade, Stage      | Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                   | ER+, PR+, Her2+                                                  | Yes          | White        | Not Hispanic or Latino | DCIS is also present, cribform type, high grade                                                                                                                                                                               | 2021-09-02 |\n",
       "|  80 | PDXNet Consortium Members | HCI | HCI-037           | K60344 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 38353 | Yes          | Stage             | Recurrence at primary site Tumor Grade/Stage: Stage IIIA Location of known metastases: Femur, pleura                                                       | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 invasive ductal breast cancer. Recurrence: (2016) ER-, PR-, Her2+ (3+) Grade 2 IDC                                                                                   | 2019-05-21 |\n",
       "|  81 | PDXNet Consortium Members | HCI | HCI-040 (305-R)   | K12432 | Female | 10006190 | Invasive breast carcinoma        | IDC                                                        | Breast | ⋯ | 38718 | Yes          | Stage             | Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                         | ER+, PR+, HER2+                                                  | Yes          | White        | Not Hispanic or Latino | History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+ | 2021-09-02 |\n",
       "|  82 | PDXNet Consortium Members | HCI | HCI-040EI (244-X) | K12432 | Female | 10006190 | Invasive breast carcinoma        | IDC                                                        | Breast | ⋯ | 38718 | Yes          | Stage             | Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                         | ER+, PR+, HER2+                                                  | Yes          | White        | Not Hispanic or Latino | History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+ | 2021-09-02 |\n",
       "|  83 | PDXNet Consortium Members | HCI | HCI-041           | K96261 | Female | 10006190 | Invasive breast carcinoma        | TNBC, metaplastic                                          | Breast | ⋯ | 43101 | Not Reported | None Provided     | -                                                                                                                                                          | ER-, PR-, Her2-                                                  | Not Provided | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  84 | PDXNet Consortium Members | HCI | HCI-042           | K74601 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 42736 | Not Reported | None Provided     | -                                                                                                                                                          | ER-, PR-, Her2-                                                  | Not Provided | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  85 | PDXNet Consortium Members | HCI | HCI-043 (060-T)   | K34576 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 43160 | Yes          | None Provided     | Location of known metastases: liver, bone, ascites                                                                                                         | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  86 | PDXNet Consortium Members | HCI | HCI-044 (182-R)   | K29053 | Female | 10006190 | Invasive breast carcinoma        | invasive ductal carcinoma                                  | Breast | ⋯ | 41944 | Yes          | None Provided     | Location of metastases: Bone, pleura                                                                                                                       | ER+, PR+, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  87 | PDXNet Consortium Members | HCI | HCI-044EI (152-X) | K29053 | Female | 10006190 | Invasive breast carcinoma        | invasive ductal carcinoma                                  | Breast | ⋯ | 41944 | Yes          | None Provided     | Location of metastases: Bone, pleura                                                                                                                       | ER+, PR+, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  88 | PDXNet Consortium Members | HCI | HCI-045           | K88866 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 43374 | Not Reported | None Provided     | -                                                                                                                                                          | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  89 | PDXNet Consortium Members | HCI | HCI-046           | K31473 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 43405 | Not Reported | None Provided     | -                                                                                                                                                          | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  90 | PDXNet Consortium Members | HCI | HCI-049           | K64320 | Female | 10006190 | Invasive breast carcinoma        | Invasive ductal carcinoma                                  | Breast | ⋯ | 43101 | Not Reported | None Provided     | -                                                                                                                                                          | ER+, PR+, Her2-                                                  | Yes          | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  91 | PDXNet Consortium Members | HCI | HCI-051 (244-M)   | K34576 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 43160 | Yes          | None Provided     | Location of known metastases: liver, bone, ascites                                                                                                         | ER-, PR-, Her2-                                                  | No           | White        | Not Hispanic or Latino | -                                                                                                                                                                                                                             | 2021-09-02 |\n",
       "|  92 | PDXNet Consortium Members | HCI | HCI-001           | K55119 | Female | 10006190 | Invasive breast carcinoma        | TNBC. IDC, papillary architecture                          | Breast | ⋯ | 39083 | Yes          | Grade, Stage      | Tumor Grade/Stage: Stage 4, Grade III Location of known metastases: Lung                                                                                   | -                                                                | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-11 |\n",
       "|  93 | PDXNet Consortium Members | HCI | HCI-002           | K50745 | Female | 10006190 | Invasive breast carcinoma        | TNBC                                                       | Breast | ⋯ | 39845 | Yes          | Grade             | Tumor Grade/Stage:  Grade III Location of known metastases: Lymph node                                                                                     | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-11 |\n",
       "|  94 | PDXNet Consortium Members | HCI | HCI-005 (336-M)   | K42072 | Female | 10006190 | Invasive breast carcinoma        | Adenocarcinoma                                             | Breast | ⋯ | 36951 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                               | ER+, PR+, HER2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-11 |\n",
       "|  95 | PDXNet Consortium Members | HCI | HCI-007 (274-M)   | K42072 | Female | 10006190 | Invasive breast carcinoma        | Adenocarcinoma                                             | Breast | ⋯ | 36951 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                               | ER+, PR+, HER2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-11 |\n",
       "|  96 | PDXNet Consortium Members | HCI | HCI-009           | K93541 | Female | 10006190 | Invasive breast carcinoma        | TNBC, apocrine features                                    | Breast | ⋯ | 31048 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pancreas, peritoneum                                                                 | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-16 |\n",
       "|  97 | PDXNet Consortium Members | HCI | HCI-010           | K16669 | Female | 10006190 | Invasive breast carcinoma        | TNBC                                                       | Breast | ⋯ | 39083 | Yes          | Stage             | Tumor Grade/Stage: Lung Location of known metastases: Lung, Pleura                                                                                         | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-16 |\n",
       "|  98 | PDXNet Consortium Members | HCI | HCI-011           | K91478 | Female | 10006190 | Invasive breast carcinoma        | IDC                                                        | Breast | ⋯ | 39326 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: lymph node, pleura                                                                               | ER+, PR+, HER2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-11 |\n",
       "|  99 | PDXNet Consortium Members | HCI | HCI-012           | K40892 | Female | 10006190 | Invasive breast carcinoma        | Adenocarcinoma                                             | Breast | ⋯ | 36526 | Yes          | None Provided     | Location of known metastases: Lymph node, pericardium                                                                                                      | ER-, PR-, Her2 not reported                                      | Not Provided | Not Provided | Not Provided           | Biomarker assessment 2 years prior showed ER-/PR-/HER2+ disease. HER2 status was not re-tested on the pleural effusion sample used to make the PDX.                                                                           | 2019-06-12 |\n",
       "| 100 | PDXNet Consortium Members | HCI | HCI-013 (M1)      | K97960 | Female | 10006190 | Invasive breast carcinoma        | Invasive lobular carcinoma                                 | Breast | ⋯ | 37742 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                         | ER+, PR+, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-07 |\n",
       "| 101 | PDXNet Consortium Members | HCI | HCI-013EI (M2)    | K97960 | Female | 10006190 | Invasive breast carcinoma        | Invasive lobular carcinoma                                 | Breast | ⋯ | 37742 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                         | ER+, PR+, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-07 |\n",
       "| 102 | PDXNet Consortium Members | HCI | HCI-015           | K90681 | Female | 10006190 | Invasive breast carcinoma        | TNBC                                                       | Breast | ⋯ | 40148 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Brain                                                                                            | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-16 |\n",
       "| 103 | PDXNet Consortium Members | HCI | HCI-016           | K17667 | Female | 10006190 | Invasive breast carcinoma        | ductal                                                     | Breast | ⋯ | 23163 | Yes          | Stage             | Tumor Grade/Stage: Stage IIIb                                                                                                                              | BRCA germline mutation, 4184del4                                 | Not Provided | Not Provided | Not Provided           | Patient history:2nd  breast cancer diagnosis but unclear if it is a recurrence or 2nd primary. Family is BRCA1+                                                                                                               | 2019-05-16 |\n",
       "| 104 | PDXNet Consortium Members | HCI | HCI-025           | K42933 | Female | 10006190 | Invasive breast carcinoma        | TNBC, invasive with squamous differentiation (metaplastic) | Breast | ⋯ | 41275 | Yes          | Grade, Stage      | Tumor Grade/Stage: Stage IV, Grade 3 Location of known metastases: SVC lymph node (LN), posterior cervical LN, anterosuperior mediastinum LN, neck, chest. | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-12 |\n",
       "| 105 | PDXNet Consortium Members | HCI | HCI-027           | K11172 | Female | 10006190 | Invasive breast carcinoma        | TNBC, IDC                                                  | Breast | ⋯ | 42614 | Yes          | Grade, Stage, TNM | Tumor Grade/Stage: Grade 3, Stage IIIC, T3N3M0 Location of known metastases: Lymph node, bone, liver                                                       | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-06-12 |\n",
       "| 106 | PDXNet Consortium Members | HCI | HCI-028           | K53784 | Female | 10006190 | Invasive breast carcinoma        | TNBC, IDC                                                  | Breast | ⋯ | 40513 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lung, Ovary, Liver, Brain                                                                  | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | Patient history shows mixed biomarker information: Primary tumor: ER+ (75%), PR-, HER2-;  Bone metastasis: ER-, PR-, HER2+; Metastatic effusion: ER-, PR-, HER2- (TNBC).                                                      | 2019-05-07 |\n",
       "| 107 | PDXNet Consortium Members | HCI | HCI-030           | K37516 | Female | 10006190 | Invasive breast carcinoma        | TNBC, IDC                                                  | Breast | ⋯ | 36161 | Not Reported | Grade, Stage, TNM | Recurrence: primary site Tumor Grade/Stage: Stage IIA, Grade 2 (poorly differentiated), T3N3Mx                                                             | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | Original diagnosis 1999, recurrence 2003, recurrence 2010                                                                                                                                                                     | 2019-05-07 |\n",
       "| 108 | PDXNet Consortium Members | HCI | HCI-033 (244-R)   | K82491 | Female | 10006190 | Invasive breast carcinoma        | TNBC, adenocarcinoma                                       | Breast | ⋯ | 38718 | Yes          | Grade, Stage      | Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung                                                        | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS                                                                                                                        | 2019-05-21 |\n",
       "| 110 | PDXNet Consortium Members | HCI | HCI-036           | K73638 | Female | 10053130 | Cystosarcoma phylloides - breast | TNBC                                                       | Breast | ⋯ | 41030 | Not Reported | None Provided     | Recurrence at primary site                                                                                                                                 | ER-, PR-, Her2-                                                  | Not Provided | Not Provided | Not Provided           | -                                                                                                                                                                                                                             | 2019-05-16 |\n",
       "| 111 | PDXNet Consortium Members | HCI | HCI-038 (121-R)   | K23558 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 38353 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                    | ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance) | Not Provided | Not Provided | Not Provided           | Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                      | 2019-05-21 |\n",
       "| 112 | PDXNet Consortium Members | HCI | HCI-039 (121-M)   | K23558 | Female | 10006190 | Invasive breast carcinoma        | TNBC, ductal                                               | Breast | ⋯ | 38353 | Yes          | Stage             | Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                    | ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance) | Not Provided | Not Provided | Not Provided           | Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                      | 2019-05-21 |\n",
       "\n"
      ],
      "text/plain": [
       "   ...1 PDXSource                 Contributor ContributorPDX.ID PDMR.Patient.ID\n",
       "1   68  PDXNet Consortium Members HCI         HCI-004           K92478         \n",
       "2   69  PDXNet Consortium Members HCI         HCI-008           K88751         \n",
       "3   70  PDXNet Consortium Members HCI         HCI-014           K39284         \n",
       "4   71  PDXNet Consortium Members HCI         HCI-017           K18605         \n",
       "5   72  PDXNet Consortium Members HCI         HCI-018           K80651         \n",
       "6   73  PDXNet Consortium Members HCI         HCI-019           K18234         \n",
       "7   74  PDXNet Consortium Members HCI         HCI-023           K65121         \n",
       "8   75  PDXNet Consortium Members HCI         HCI-028LV         K71592         \n",
       "9   76  PDXNet Consortium Members HCI         HCI-031 (153-M)   K61826         \n",
       "10  77  PDXNet Consortium Members HCI         HCI-031OV (305-X) K61826         \n",
       "11  78  PDXNet Consortium Members HCI         HCI-032 (231-R)   K07497         \n",
       "12  79  PDXNet Consortium Members HCI         HCI-032EI (152-X) K07497         \n",
       "13  80  PDXNet Consortium Members HCI         HCI-037           K60344         \n",
       "14  81  PDXNet Consortium Members HCI         HCI-040 (305-R)   K12432         \n",
       "15  82  PDXNet Consortium Members HCI         HCI-040EI (244-X) K12432         \n",
       "16  83  PDXNet Consortium Members HCI         HCI-041           K96261         \n",
       "17  84  PDXNet Consortium Members HCI         HCI-042           K74601         \n",
       "18  85  PDXNet Consortium Members HCI         HCI-043 (060-T)   K34576         \n",
       "19  86  PDXNet Consortium Members HCI         HCI-044 (182-R)   K29053         \n",
       "20  87  PDXNet Consortium Members HCI         HCI-044EI (152-X) K29053         \n",
       "21  88  PDXNet Consortium Members HCI         HCI-045           K88866         \n",
       "22  89  PDXNet Consortium Members HCI         HCI-046           K31473         \n",
       "23  90  PDXNet Consortium Members HCI         HCI-049           K64320         \n",
       "24  91  PDXNet Consortium Members HCI         HCI-051 (244-M)   K34576         \n",
       "25  92  PDXNet Consortium Members HCI         HCI-001           K55119         \n",
       "26  93  PDXNet Consortium Members HCI         HCI-002           K50745         \n",
       "27  94  PDXNet Consortium Members HCI         HCI-005 (336-M)   K42072         \n",
       "28  95  PDXNet Consortium Members HCI         HCI-007 (274-M)   K42072         \n",
       "29  96  PDXNet Consortium Members HCI         HCI-009           K93541         \n",
       "30  97  PDXNet Consortium Members HCI         HCI-010           K16669         \n",
       "31  98  PDXNet Consortium Members HCI         HCI-011           K91478         \n",
       "32  99  PDXNet Consortium Members HCI         HCI-012           K40892         \n",
       "33 100  PDXNet Consortium Members HCI         HCI-013 (M1)      K97960         \n",
       "34 101  PDXNet Consortium Members HCI         HCI-013EI (M2)    K97960         \n",
       "35 102  PDXNet Consortium Members HCI         HCI-015           K90681         \n",
       "36 103  PDXNet Consortium Members HCI         HCI-016           K17667         \n",
       "37 104  PDXNet Consortium Members HCI         HCI-025           K42933         \n",
       "38 105  PDXNet Consortium Members HCI         HCI-027           K11172         \n",
       "39 106  PDXNet Consortium Members HCI         HCI-028           K53784         \n",
       "40 107  PDXNet Consortium Members HCI         HCI-030           K37516         \n",
       "41 108  PDXNet Consortium Members HCI         HCI-033 (244-R)   K82491         \n",
       "42 110  PDXNet Consortium Members HCI         HCI-036           K73638         \n",
       "43 111  PDXNet Consortium Members HCI         HCI-038 (121-R)   K23558         \n",
       "44 112  PDXNet Consortium Members HCI         HCI-039 (121-M)   K23558         \n",
       "   Gender CTEP.SDCCode CTEP.SDCDescription             \n",
       "1  Female 10006190     Invasive breast carcinoma       \n",
       "2  Female 10006190     Invasive breast carcinoma       \n",
       "3  Female 10006190     Invasive breast carcinoma       \n",
       "4  Female 10006190     Invasive breast carcinoma       \n",
       "5  Female 10006190     Invasive breast carcinoma       \n",
       "6  Female 10006190     Invasive breast carcinoma       \n",
       "7  Female 10006190     Invasive breast carcinoma       \n",
       "8  Female 10006190     Invasive breast carcinoma       \n",
       "9  Female 10006190     Invasive breast carcinoma       \n",
       "10 Female 10006190     Invasive breast carcinoma       \n",
       "11 Female 10006190     Invasive breast carcinoma       \n",
       "12 Female 10006190     Invasive breast carcinoma       \n",
       "13 Female 10006190     Invasive breast carcinoma       \n",
       "14 Female 10006190     Invasive breast carcinoma       \n",
       "15 Female 10006190     Invasive breast carcinoma       \n",
       "16 Female 10006190     Invasive breast carcinoma       \n",
       "17 Female 10006190     Invasive breast carcinoma       \n",
       "18 Female 10006190     Invasive breast carcinoma       \n",
       "19 Female 10006190     Invasive breast carcinoma       \n",
       "20 Female 10006190     Invasive breast carcinoma       \n",
       "21 Female 10006190     Invasive breast carcinoma       \n",
       "22 Female 10006190     Invasive breast carcinoma       \n",
       "23 Female 10006190     Invasive breast carcinoma       \n",
       "24 Female 10006190     Invasive breast carcinoma       \n",
       "25 Female 10006190     Invasive breast carcinoma       \n",
       "26 Female 10006190     Invasive breast carcinoma       \n",
       "27 Female 10006190     Invasive breast carcinoma       \n",
       "28 Female 10006190     Invasive breast carcinoma       \n",
       "29 Female 10006190     Invasive breast carcinoma       \n",
       "30 Female 10006190     Invasive breast carcinoma       \n",
       "31 Female 10006190     Invasive breast carcinoma       \n",
       "32 Female 10006190     Invasive breast carcinoma       \n",
       "33 Female 10006190     Invasive breast carcinoma       \n",
       "34 Female 10006190     Invasive breast carcinoma       \n",
       "35 Female 10006190     Invasive breast carcinoma       \n",
       "36 Female 10006190     Invasive breast carcinoma       \n",
       "37 Female 10006190     Invasive breast carcinoma       \n",
       "38 Female 10006190     Invasive breast carcinoma       \n",
       "39 Female 10006190     Invasive breast carcinoma       \n",
       "40 Female 10006190     Invasive breast carcinoma       \n",
       "41 Female 10006190     Invasive breast carcinoma       \n",
       "42 Female 10053130     Cystosarcoma phylloides - breast\n",
       "43 Female 10006190     Invasive breast carcinoma       \n",
       "44 Female 10006190     Invasive breast carcinoma       \n",
       "   DiagnosisSubtype                                          \n",
       "1  TNBC                                                      \n",
       "2  -                                                         \n",
       "3  TNBC, Infiltrating lobular adenocarcinoma                 \n",
       "4  ductal                                                    \n",
       "5  Invasive lobular carcinoma with focal signet ring features\n",
       "6  TNBC, IDC with apocrine features                          \n",
       "7  TNBC                                                      \n",
       "8  TNBC, adenocarcinoma                                      \n",
       "9  TNBC, lobular                                             \n",
       "10 TNBC, lobular                                             \n",
       "11 IDC with apocrine and micropapillary features.            \n",
       "12 IDC with apocrine and micropapillary features.            \n",
       "13 TNBC, ductal                                              \n",
       "14 IDC                                                       \n",
       "15 IDC                                                       \n",
       "16 TNBC, metaplastic                                         \n",
       "17 TNBC, ductal                                              \n",
       "18 TNBC, ductal                                              \n",
       "19 invasive ductal carcinoma                                 \n",
       "20 invasive ductal carcinoma                                 \n",
       "21 TNBC, ductal                                              \n",
       "22 TNBC, ductal                                              \n",
       "23 Invasive ductal carcinoma                                 \n",
       "24 TNBC, ductal                                              \n",
       "25 TNBC. IDC, papillary architecture                         \n",
       "26 TNBC                                                      \n",
       "27 Adenocarcinoma                                            \n",
       "28 Adenocarcinoma                                            \n",
       "29 TNBC, apocrine features                                   \n",
       "30 TNBC                                                      \n",
       "31 IDC                                                       \n",
       "32 Adenocarcinoma                                            \n",
       "33 Invasive lobular carcinoma                                \n",
       "34 Invasive lobular carcinoma                                \n",
       "35 TNBC                                                      \n",
       "36 ductal                                                    \n",
       "37 TNBC, invasive with squamous differentiation (metaplastic)\n",
       "38 TNBC, IDC                                                 \n",
       "39 TNBC, IDC                                                 \n",
       "40 TNBC, IDC                                                 \n",
       "41 TNBC, adenocarcinoma                                      \n",
       "42 TNBC                                                      \n",
       "43 TNBC, ductal                                              \n",
       "44 TNBC, ductal                                              \n",
       "   Disease.BodyLocation ⋯ Date.ofDiagnosis Has.KnownMetastaticDisease\n",
       "1  Breast               ⋯ 39995            Not Reported              \n",
       "2  Breast               ⋯ 39083            Yes                       \n",
       "3  Breast               ⋯ 39904            Yes                       \n",
       "4  Breast               ⋯ 41153            Yes                       \n",
       "5  Breast               ⋯ 37012            Yes                       \n",
       "6  Breast               ⋯ 41456            Not Reported              \n",
       "7  Breast               ⋯ 41640            Yes                       \n",
       "8  Breast               ⋯ 40513            Yes                       \n",
       "9  Breast               ⋯ 39845            Yes                       \n",
       "10 Breast               ⋯ 39845            Yes                       \n",
       "11 Breast               ⋯ 42186            Yes                       \n",
       "12 Breast               ⋯ 42186            Yes                       \n",
       "13 Breast               ⋯ 38353            Yes                       \n",
       "14 Breast               ⋯ 38718            Yes                       \n",
       "15 Breast               ⋯ 38718            Yes                       \n",
       "16 Breast               ⋯ 43101            Not Reported              \n",
       "17 Breast               ⋯ 42736            Not Reported              \n",
       "18 Breast               ⋯ 43160            Yes                       \n",
       "19 Breast               ⋯ 41944            Yes                       \n",
       "20 Breast               ⋯ 41944            Yes                       \n",
       "21 Breast               ⋯ 43374            Not Reported              \n",
       "22 Breast               ⋯ 43405            Not Reported              \n",
       "23 Breast               ⋯ 43101            Not Reported              \n",
       "24 Breast               ⋯ 43160            Yes                       \n",
       "25 Breast               ⋯ 39083            Yes                       \n",
       "26 Breast               ⋯ 39845            Yes                       \n",
       "27 Breast               ⋯ 36951            Yes                       \n",
       "28 Breast               ⋯ 36951            Yes                       \n",
       "29 Breast               ⋯ 31048            Yes                       \n",
       "30 Breast               ⋯ 39083            Yes                       \n",
       "31 Breast               ⋯ 39326            Yes                       \n",
       "32 Breast               ⋯ 36526            Yes                       \n",
       "33 Breast               ⋯ 37742            Yes                       \n",
       "34 Breast               ⋯ 37742            Yes                       \n",
       "35 Breast               ⋯ 40148            Yes                       \n",
       "36 Breast               ⋯ 23163            Yes                       \n",
       "37 Breast               ⋯ 41275            Yes                       \n",
       "38 Breast               ⋯ 42614            Yes                       \n",
       "39 Breast               ⋯ 40513            Yes                       \n",
       "40 Breast               ⋯ 36161            Not Reported              \n",
       "41 Breast               ⋯ 38718            Yes                       \n",
       "42 Breast               ⋯ 41030            Not Reported              \n",
       "43 Breast               ⋯ 38353            Yes                       \n",
       "44 Breast               ⋯ 38353            Yes                       \n",
       "   Grade.StageInformation\n",
       "1  None Provided         \n",
       "2  Stage                 \n",
       "3  Grade, Stage          \n",
       "4  None Provided         \n",
       "5  Stage                 \n",
       "6  None Provided         \n",
       "7  None Provided         \n",
       "8  Stage                 \n",
       "9  None Provided         \n",
       "10 None Provided         \n",
       "11 Grade, Stage          \n",
       "12 Grade, Stage          \n",
       "13 Stage                 \n",
       "14 Stage                 \n",
       "15 Stage                 \n",
       "16 None Provided         \n",
       "17 None Provided         \n",
       "18 None Provided         \n",
       "19 None Provided         \n",
       "20 None Provided         \n",
       "21 None Provided         \n",
       "22 None Provided         \n",
       "23 None Provided         \n",
       "24 None Provided         \n",
       "25 Grade, Stage          \n",
       "26 Grade                 \n",
       "27 Stage                 \n",
       "28 Stage                 \n",
       "29 Stage                 \n",
       "30 Stage                 \n",
       "31 Stage                 \n",
       "32 None Provided         \n",
       "33 Stage                 \n",
       "34 Stage                 \n",
       "35 Stage                 \n",
       "36 Stage                 \n",
       "37 Grade, Stage          \n",
       "38 Grade, Stage, TNM     \n",
       "39 Stage                 \n",
       "40 Grade, Stage, TNM     \n",
       "41 Grade, Stage          \n",
       "42 None Provided         \n",
       "43 Stage                 \n",
       "44 Stage                 \n",
       "   PatientNotes                                                                                                                                              \n",
       "1  Tumor Grade/Stage: Stage IIA, Grade III, Poorly differentiated                                                                                            \n",
       "2  Tumor Grade/Stage: Stage IV Location of known metastases: Pleura                                                                                          \n",
       "3  Tumor Grade/Stage: Stage IV, Grade II Location of known metastases: Bone, Pleura                                                                          \n",
       "4  Location of known metastases: Brain, bone, lung                                                                                                           \n",
       "5  Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Bone, Ovary                                                                              \n",
       "6  Tumor Stage/Grade: poorly differentiated                                                                                                                  \n",
       "7  Tumor Grade/Stage: Stage IIA, Grade II, Poorly differentiated Location of known metastases: Brain, Lung, Bone                                             \n",
       "8  Tumor Grade/Stage: Stage IV Location of known metastases: bone, pleura, brain                                                                             \n",
       "9  Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                               \n",
       "10 Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain                                                               \n",
       "11 Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                  \n",
       "12 Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis                                                  \n",
       "13 Recurrence at primary site Tumor Grade/Stage: Stage IIIA Location of known metastases: Femur, pleura                                                      \n",
       "14 Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                        \n",
       "15 Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur                                                        \n",
       "16 -                                                                                                                                                         \n",
       "17 -                                                                                                                                                         \n",
       "18 Location of known metastases: liver, bone, ascites                                                                                                        \n",
       "19 Location of metastases: Bone, pleura                                                                                                                      \n",
       "20 Location of metastases: Bone, pleura                                                                                                                      \n",
       "21 -                                                                                                                                                         \n",
       "22 -                                                                                                                                                         \n",
       "23 -                                                                                                                                                         \n",
       "24 Location of known metastases: liver, bone, ascites                                                                                                        \n",
       "25 Tumor Grade/Stage: Stage 4, Grade III Location of known metastases: Lung                                                                                  \n",
       "26 Tumor Grade/Stage:  Grade III Location of known metastases: Lymph node                                                                                    \n",
       "27 Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                              \n",
       "28 Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura                                                                              \n",
       "29 Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pancreas, peritoneum                                                                \n",
       "30 Tumor Grade/Stage: Lung Location of known metastases: Lung, Pleura                                                                                        \n",
       "31 Tumor Grade/Stage: Stage IV Location of known metastases: lymph node, pleura                                                                              \n",
       "32 Location of known metastases: Lymph node, pericardium                                                                                                     \n",
       "33 Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                        \n",
       "34 Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium                                                                        \n",
       "35 Tumor Grade/Stage: Stage IV Location of known metastases: Brain                                                                                           \n",
       "36 Tumor Grade/Stage: Stage IIIb                                                                                                                             \n",
       "37 Tumor Grade/Stage: Stage IV, Grade 3 Location of known metastases: SVC lymph node (LN), posterior cervical LN, anterosuperior mediastinum LN, neck, chest.\n",
       "38 Tumor Grade/Stage: Grade 3, Stage IIIC, T3N3M0 Location of known metastases: Lymph node, bone, liver                                                      \n",
       "39 Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lung, Ovary, Liver, Brain                                                                 \n",
       "40 Recurrence: primary site Tumor Grade/Stage: Stage IIA, Grade 2 (poorly differentiated), T3N3Mx                                                            \n",
       "41 Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung                                                       \n",
       "42 Recurrence at primary site                                                                                                                                \n",
       "43 Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                   \n",
       "44 Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura                                                                                   \n",
       "   Molecular.andIHC.Data                                           \n",
       "1  ER-, PR-, Her2-                                                 \n",
       "2  ER-, PR-, Her2+                                                 \n",
       "3  ER-, PR-, HER2-; Her2 IHC (2+); Her2 not amplified (FISH)       \n",
       "4  ER+, PR+, Her2-                                                 \n",
       "5  ER+, PR-, Her2-                                                 \n",
       "6  ER- (1%), PR- (1%), Her2-                                       \n",
       "7  ER-, PR-, Her2-                                                 \n",
       "8  ER-, PR-, Her2-                                                 \n",
       "9  ER-, PR-, Her2-                                                 \n",
       "10 ER-, PR-, Her2-                                                 \n",
       "11 ER+, PR+, Her2+                                                 \n",
       "12 ER+, PR+, Her2+                                                 \n",
       "13 ER-, PR-, Her2-                                                 \n",
       "14 ER+, PR+, HER2+                                                 \n",
       "15 ER+, PR+, HER2+                                                 \n",
       "16 ER-, PR-, Her2-                                                 \n",
       "17 ER-, PR-, Her2-                                                 \n",
       "18 ER-, PR-, Her2-                                                 \n",
       "19 ER+, PR+, Her2-                                                 \n",
       "20 ER+, PR+, Her2-                                                 \n",
       "21 ER-, PR-, Her2-                                                 \n",
       "22 ER-, PR-, Her2-                                                 \n",
       "23 ER+, PR+, Her2-                                                 \n",
       "24 ER-, PR-, Her2-                                                 \n",
       "25 -                                                               \n",
       "26 ER-, PR-, Her2-                                                 \n",
       "27 ER+, PR+, HER2-                                                 \n",
       "28 ER+, PR+, HER2-                                                 \n",
       "29 ER-, PR-, Her2-                                                 \n",
       "30 ER-, PR-, Her2-                                                 \n",
       "31 ER+, PR+, HER2-                                                 \n",
       "32 ER-, PR-, Her2 not reported                                     \n",
       "33 ER+, PR+, Her2-                                                 \n",
       "34 ER+, PR+, Her2-                                                 \n",
       "35 ER-, PR-, Her2-                                                 \n",
       "36 BRCA germline mutation, 4184del4                                \n",
       "37 ER-, PR-, Her2-                                                 \n",
       "38 ER-, PR-, Her2-                                                 \n",
       "39 ER-, PR-, Her2-                                                 \n",
       "40 ER-, PR-, Her2-                                                 \n",
       "41 ER-, PR-, Her2-                                                 \n",
       "42 ER-, PR-, Her2-                                                 \n",
       "43 ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)\n",
       "44 ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)\n",
       "   Has.Smoked100.Cigarettes Race         Ethnicity             \n",
       "1  No                       White        Hispanic or Latino    \n",
       "2  No                       White        Not Hispanic or Latino\n",
       "3  No                       White        Not Provided          \n",
       "4  No                       White        Not Hispanic or Latino\n",
       "5  No                       Not Provided Not Provided          \n",
       "6  Not Provided             Not Provided Hispanic or Latino    \n",
       "7  No                       White        Not Hispanic or Latino\n",
       "8  Not Provided             White        Not Hispanic or Latino\n",
       "9  No                       White        Not Hispanic or Latino\n",
       "10 No                       White        Not Hispanic or Latino\n",
       "11 Yes                      White        Not Hispanic or Latino\n",
       "12 Yes                      White        Not Hispanic or Latino\n",
       "13 Not Provided             Not Provided Not Provided          \n",
       "14 Yes                      White        Not Hispanic or Latino\n",
       "15 Yes                      White        Not Hispanic or Latino\n",
       "16 Not Provided             White        Not Hispanic or Latino\n",
       "17 Not Provided             White        Not Hispanic or Latino\n",
       "18 No                       White        Not Hispanic or Latino\n",
       "19 No                       White        Not Hispanic or Latino\n",
       "20 No                       White        Not Hispanic or Latino\n",
       "21 No                       White        Not Hispanic or Latino\n",
       "22 No                       White        Not Hispanic or Latino\n",
       "23 Yes                      White        Not Hispanic or Latino\n",
       "24 No                       White        Not Hispanic or Latino\n",
       "25 Not Provided             Not Provided Not Provided          \n",
       "26 Not Provided             Not Provided Not Provided          \n",
       "27 Not Provided             Not Provided Not Provided          \n",
       "28 Not Provided             Not Provided Not Provided          \n",
       "29 Not Provided             Not Provided Not Provided          \n",
       "30 Not Provided             Not Provided Not Provided          \n",
       "31 Not Provided             Not Provided Not Provided          \n",
       "32 Not Provided             Not Provided Not Provided          \n",
       "33 Not Provided             Not Provided Not Provided          \n",
       "34 Not Provided             Not Provided Not Provided          \n",
       "35 Not Provided             Not Provided Not Provided          \n",
       "36 Not Provided             Not Provided Not Provided          \n",
       "37 Not Provided             Not Provided Not Provided          \n",
       "38 Not Provided             Not Provided Not Provided          \n",
       "39 Not Provided             Not Provided Not Provided          \n",
       "40 Not Provided             Not Provided Not Provided          \n",
       "41 Not Provided             Not Provided Not Provided          \n",
       "42 Not Provided             Not Provided Not Provided          \n",
       "43 Not Provided             Not Provided Not Provided          \n",
       "44 Not Provided             Not Provided Not Provided          \n",
       "   AdditionalMedicalHistory                                                                                                                                                                                                     \n",
       "1  -                                                                                                                                                                                                                            \n",
       "2  -                                                                                                                                                                                                                            \n",
       "3  -                                                                                                                                                                                                                            \n",
       "4  -                                                                                                                                                                                                                            \n",
       "5  Disease Progression: Invasive breast carcinoma, Stage IIIA (2001); Invasive lobular carcinoma, Stage IV (2003)                                                                                                               \n",
       "6  -                                                                                                                                                                                                                            \n",
       "7  -                                                                                                                                                                                                                            \n",
       "8  History of: ER+ (75%), PR-, Her2- in primary tumor and ER-, PR-, Her2+ in bone metastases; reported history of ER+, PR+, Her2- breast cancer micropapillary type with apocrine features                                      \n",
       "9  History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                            \n",
       "10 History of: ER+, PR+, Her2- lobular breast cancer                                                                                                                                                                            \n",
       "11 DCIS is also present, cribform type, high grade                                                                                                                                                                              \n",
       "12 DCIS is also present, cribform type, high grade                                                                                                                                                                              \n",
       "13 Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 invasive ductal breast cancer. Recurrence: (2016) ER-, PR-, Her2+ (3+) Grade 2 IDC                                                                                  \n",
       "14 History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+\n",
       "15 History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+\n",
       "16 -                                                                                                                                                                                                                            \n",
       "17 -                                                                                                                                                                                                                            \n",
       "18 -                                                                                                                                                                                                                            \n",
       "19 -                                                                                                                                                                                                                            \n",
       "20 -                                                                                                                                                                                                                            \n",
       "21 -                                                                                                                                                                                                                            \n",
       "22 -                                                                                                                                                                                                                            \n",
       "23 -                                                                                                                                                                                                                            \n",
       "24 -                                                                                                                                                                                                                            \n",
       "25 -                                                                                                                                                                                                                            \n",
       "26 -                                                                                                                                                                                                                            \n",
       "27 -                                                                                                                                                                                                                            \n",
       "28 -                                                                                                                                                                                                                            \n",
       "29 -                                                                                                                                                                                                                            \n",
       "30 -                                                                                                                                                                                                                            \n",
       "31 -                                                                                                                                                                                                                            \n",
       "32 Biomarker assessment 2 years prior showed ER-/PR-/HER2+ disease. HER2 status was not re-tested on the pleural effusion sample used to make the PDX.                                                                          \n",
       "33 -                                                                                                                                                                                                                            \n",
       "34 -                                                                                                                                                                                                                            \n",
       "35 -                                                                                                                                                                                                                            \n",
       "36 Patient history:2nd  breast cancer diagnosis but unclear if it is a recurrence or 2nd primary. Family is BRCA1+                                                                                                              \n",
       "37 -                                                                                                                                                                                                                            \n",
       "38 -                                                                                                                                                                                                                            \n",
       "39 Patient history shows mixed biomarker information: Primary tumor: ER+ (75%), PR-, HER2-;  Bone metastasis: ER-, PR-, HER2+; Metastatic effusion: ER-, PR-, HER2- (TNBC).                                                     \n",
       "40 Original diagnosis 1999, recurrence 2003, recurrence 2010                                                                                                                                                                    \n",
       "41 Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS                                                                                                                       \n",
       "42 -                                                                                                                                                                                                                            \n",
       "43 Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                     \n",
       "44 Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca                                                                                                     \n",
       "   Submission\n",
       "1  2021-09-02\n",
       "2  2021-09-02\n",
       "3  2021-09-02\n",
       "4  2021-09-02\n",
       "5  2021-09-02\n",
       "6  2019-05-07\n",
       "7  2021-09-02\n",
       "8  2021-09-02\n",
       "9  2021-09-02\n",
       "10 2021-09-02\n",
       "11 2021-09-02\n",
       "12 2021-09-02\n",
       "13 2019-05-21\n",
       "14 2021-09-02\n",
       "15 2021-09-02\n",
       "16 2021-09-02\n",
       "17 2021-09-02\n",
       "18 2021-09-02\n",
       "19 2021-09-02\n",
       "20 2021-09-02\n",
       "21 2021-09-02\n",
       "22 2021-09-02\n",
       "23 2021-09-02\n",
       "24 2021-09-02\n",
       "25 2019-06-11\n",
       "26 2019-06-11\n",
       "27 2019-06-11\n",
       "28 2019-06-11\n",
       "29 2019-05-16\n",
       "30 2019-05-16\n",
       "31 2019-06-11\n",
       "32 2019-06-12\n",
       "33 2019-05-07\n",
       "34 2019-05-07\n",
       "35 2019-05-16\n",
       "36 2019-05-16\n",
       "37 2019-06-12\n",
       "38 2019-06-12\n",
       "39 2019-05-07\n",
       "40 2019-05-07\n",
       "41 2019-05-21\n",
       "42 2019-05-16\n",
       "43 2019-05-21\n",
       "44 2019-05-21"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pdtc_models <- pdtc_models %>% mutate(ContributorPDX.ID = ifelse(Contributor == 'HCI', str_replace(ContributorPDX.ID, '^(?!.*HCI-)HCI', 'HCI-'), ContributorPDX.ID))\n",
    "\n",
    "# Check the HCI ones for formatting\n",
    "pdtc_models %>% filter(Contributor == 'HCI')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "2e4a2364-c988-4692-abcc-04dc35105c29",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Export\n",
    "colnames(pdtc_models)[1] <- ''\n",
    "write_csv(pdtc_models, '2022-02-18_pdxnet_portal_pdtc_models.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9bc458e2-e1d0-4c19-8252-da17278ddbd8",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.1.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
